Semax and Selank are the two most-discussed Russian research peptides in the nootropic space, and they come up together constantly because they are frequently sourced from the same suppliers and studied side by side. They are not interchangeable: Semax is studied primarily as a nootropic (cognitive/focus), Selank primarily as an anxiolytic (calming/anti-anxiety). This guide compares their mechanisms, research routes, and how researchers decide between them — or run both.
Semax vs Selank at a glance
| Semax | Selank | |
|---|---|---|
| Primary research focus | Nootropic — focus, memory, neuroprotection | Anxiolytic — calm, mood, anti-anxiety |
| Origin | Russian-developed, ACTH(4-10) fragment analog | Russian-developed, tuftsin analog |
| Typical research route | Intranasal or subcutaneous | Intranasal or subcutaneous |
| Reported onset | Cumulative — often days of consistent use | Fast — many reports within 24–48 hours |
| Secondary effect | Can be mildly stimulating | Mild secondary nootropic effect |
| Half-life | ~30 minutes | ~30 minutes |
Mechanism: why they pair rather than overlap
Semax is an analog of a fragment of ACTH (adrenocorticotropic hormone) and is studied for effects on BDNF expression, dopaminergic and serotonergic signaling, and neuroprotection. Selank is a synthetic analog of the immunomodulatory peptide tuftsin and is studied mainly for anxiolytic and mood-regulating activity, with proposed action on GABAergic and monoamine systems. Because their primary mechanisms differ, researchers often describe them as complementary rather than redundant: Semax leaning toward cognitive activation, Selank toward calm.
Research routes and handling
Both peptides are short-lived (≈30-minute half-life) and are studied via both intranasal and subcutaneous routes. The intranasal route is frequently preferred in community research for convenience and for potentially easier passage across the blood–brain barrier. Both ship lyophilized and require reconstitution before use — see the peptide reconstitution guide for the concentration math. Some researchers note Semax can feel over-stimulating at higher amounts, which is one reason the two are often dosed at different times of day.
Can you stack Semax and Selank?
A common research configuration pairs them: Selank for the anxiolytic axis and Semax for the cognitive axis. Reports frequently describe running Selank earlier in the day for calm and Semax for focus, sometimes separating the two rather than combining them in a single preparation. Bastion offers both individually and as part of a pre-paired Cognitive Stack. Whether to combine in one vial or keep them separate is a handling decision; the underlying compounds are independent.
Which one fits the research question?
- Studying focus, memory, or neuroprotection? Semax is the cognitive-axis compound. See the Semax research guide.
- Studying anxiety, stress response, or mood? Selank is the anxiolytic-axis compound. See the Selank research guide.
- Modeling both axes? The two are routinely co-studied; the Cognitive Stack groups them.
Sourcing: purity matters for both
The nootropic-peptide market is noisy, and both compounds are only as good as their verification. Look for a named independent laboratory and a per-batch certificate you can confirm yourself — not a “third-party tested” claim with no viewable report. Every Bastion batch of Semax and Selank ships with a batch-matched Janoshik COA; you can verify it in 60 seconds against the lab’s records, and the full archive is on the lab results page.
Frequently asked questions
Is Semax or Selank better? Neither — they target different systems. Semax is the nootropic; Selank is the anxiolytic. The “better” one depends on the research endpoint.
Can Semax and Selank be used together? They are commonly co-studied. Many protocols keep them separate by time of day rather than combining them in one preparation.
Why is Selank felt faster than Semax? Anxiolytic effects in Selank research are often reported within 24–48 hours, whereas Semax’s cognitive effects are more commonly described as cumulative over days of consistent use.
Which route is used in research? Both intranasal and subcutaneous are studied; intranasal is frequently preferred for convenience and blood–brain-barrier considerations.
For research use only. Not for human or veterinary consumption.